#80 Sleep Apnea & Surgical Neurostimulation with Kirk Huntsman: FDA Breakthroughs, Childhood Prevention and the CPAP Controversy

Kirk Huntsman, CEO of Vivos Therapeutics, a pioneer in the treatment of obstructive sleep apnea. With decades of experience in the dental and medtech space, Kirk has led Vivos to secure multiple FDA clearances including the first ever for treating moderate to severe pediatric sleep apnea using an oral applianceIn this episode, we uncover why sleep apnea is a silent global epidemic, why it's so underdiagnosed and how Vivos is transforming the way we approach treatment, shifting from CPAP-based management to true rehabilitation. Kirk also shares how Vivos is achieving life-changing results in less than a year, and why even mild, untreated sleep apnea can lead to serious downstream health issues like hypertension, depression and cognitive decline. We also discuss societal misperceptions, global prevalence and exciting innovations that could one day lead to a cureTimestamps:[00:00:27] What Is Obstructive Sleep Apnea and Why It’s Dangerous[00:03:07] Why Sleep Apnea Remains Widely Undiagnosed[00:06:49] Changing the Narrative Around Snoring and Awareness[00:08:49] FDA Breakthroughs: Treating Children and Adults Differently[00:13:13] CPAP vs Vivos: Why Patients Need a Third Option[00:17:26] From Dentistry to MedTech: The Journey to Founding Vivos[00:26:07] The Future of Sleep Medicine and Ending Apnea PermanentlyGet in touch with Kirk - https://www.linkedin.com/in/kirkhuntsman Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast